Catalog No. :	CL2132
Product Name :	Paricalcitol
CAS No. :	131918-61-1
Synonyms :	Paricalcitol
Chemical Name :	(1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol
Molecular Formula :	C27H44O3
Molecular Weight :	416.64
Molecular Structure :
Appearance :	White to off-white solid
Specification :	99+%
Application :	Targeting a range of conditions associated with inflammation, oxidative stress, and kidney function. 
Registration :
Storage Condition :	4°C, protect from light, stored under nitrogen

Paricalcitol, a selective VDR agonist, effectively suppresses PTH mRNA and inhibits parathyroid cell growth, treating secondary hyperparathyroidism in CKD. It's also associated with lower morbidity and improved survival rates compared to other VDRAs, with a favorable side-effect profile. Additionally, paricalcitol exhibits anti-inflammatory effects, potentially beneficial in managing CKD-related inflammation.

Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.